Viewing Study NCT05655520


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT05655520
Status: TERMINATED
Last Update Posted: 2025-12-17
First Post: 2022-12-09
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease
Sponsor: Supernus Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-12-14
Start Date Type: ACTUAL
Primary Completion Date: 2025-01-20
Primary Completion Date Type: ACTUAL
Completion Date: 2025-01-20
Completion Date Type: ACTUAL
First Submit Date: 2022-12-09
First Submit QC Date: None
Study First Post Date: 2022-12-19
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-08-20
Results First Submit QC Date: None
Results First Post Date: 2025-12-17
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-02
Last Update Post Date: 2025-12-17
Last Update Post Date Type: ESTIMATED